Biotinyl tyramide

CAS No. 41994-02-9

Biotinyl tyramide( —— )

Catalog No. M24383 CAS No. 41994-02-9

Biotinyl tyramide, a biotin derivative, is used for tyramide signal amplification, as a reagent to amplify both in situ hybridization and immunohistochemical signals protocols.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
5MG 29 In Stock
10MG 38 In Stock
25MG 58 In Stock
50MG 76 In Stock
100MG 113 In Stock
200MG Get Quote In Stock
500MG 274 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Biotinyl tyramide
  • Note
    Research use only, not for human use.
  • Brief Description
    Biotinyl tyramide, a biotin derivative, is used for tyramide signal amplification, as a reagent to amplify both in situ hybridization and immunohistochemical signals protocols.
  • Description
    Biotinyl tyramide, a biotin derivative, is used for tyramide signal amplification, as a reagent to amplify both in situ hybridization and immunohistochemical signals protocols.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    41994-02-9
  • Formula Weight
    363.47
  • Molecular Formula
    C18H25N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL (687.81 mM; Need ultrasonic)
  • SMILES
    C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCC3=CC=C(C=C3)O)NC(=O)N2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bobrow MN, et al. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods. 1989 Dec 20;125(1-2):279-85.
molnova catalog
related products
  • BI-0474

    BI-0474 is a potent KRASG12C inhibitor that inhibits GDP-KRAS::SOS1 protein-protein interactions with an IC50 value of 7.0 nM.BI-0474 exhibits significant antiproliferative activity against NCI-H358 cells harboring the G12C mutation, and shows significant anti-tumor activity in a non-small cell lung cancer xenograft model.

  • Pivagabine

    Pivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.

  • (Pro34)-Neuropeptide...

    [Pro34]Neuropeptide Y, porcine is a selective NPY receptor (Y1 receptor) agonist. [Pro34]Neuropeptide Y, porcine evokesvasoconstrictions in the guinea pig caval vein.